CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Sinopharm Group Signs Three-Year Supply Purchase Agreement With CNPGC

By Public Technologies
  • Sinopharm Group signed five framework agreements on Nov. 9, 2026, covering procurement, sales, construction contracting, factoring and financial services.
  • The agreements run from Jan. 1, 2027, through Dec. 31, 2029; procurement and financial services agreements require independent shareholder approval.
  • Proposed annual transaction caps with CNPGC are RMB 7.2 billion for procurement and RMB 2 billion for sales throughout the term.
  • Construction contracting caps rise from RMB 790 million in 2027 to RMB 915 million in 2028 and RMB 1.07 billion in 2029.
  • The proposed maximum daily deposit balance, including accrued interest, increases to RMB 5 billion from RMB 2.63 billion under the existing agreement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261109-12406173), on November 09, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk